Global Standardized Financials

132.87 0.19(0.14%)05/17/2024
Moderna Inc (MRNA)

Income Statement
(Values in USD Thousands)
 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Income-1,175,000-3,630,000-1,380,00079,000
Revenue167,0001,831,000344,0001,862,000
Cost Of Revenue132,0002,241,000731,000792,000
gross Profit35,000-410,000-387,0001,070,000
Operating Expenses1,301,0001,602,0001,480,0001,436,000
Selling General and Administrative Expenses274,000442,000332,000305,000
Research and Development Expenses1,027,0001,160,0001,148,0001,131,000
Other Expenses2,000-51,00014,000-48,000
Cost And Expenses1,433,0003,843,0002,211,0002,228,000
Operating Income-1,266,000-2,012,000-1,867,000-366,000
Interest Income120,000105,000104,000109,000
Income Tax Expense10,0001,672,000-369,000-384,000
Income Before Tax-1,165,000-1,958,000-1,749,000-305,000
Earning Per Share Basic-3.08-9.53-3.620.20
Earning Per Share Diluted-3.08-9.53-3.620.19
weighted Average Shares Outstanding382,000381,000381,000386,000
weighted Average Shares Outstanding (Diluted)382,000381,000381,000405,000
Gross Margin0.21-0.22-1.130.57
EBIT Margin-7.37-0.96-5.16-0.15
Profit Margin-7.04-1.98-4.010.04
EBITDA-1,230,000-1,763,000-1,775,000-288,000
Earning Before Tax Margin-6.98-1.07-5.08-0.16